CarrerasPathfinders · Enabling the next generation in search of blood cancer cures

Lines connect the coordinator with its partners.

Project objective

The CarrerasPathfinder program is new a world-wide unique doctoral program that covers the entire spectrum of research and innovation in blood cancers from understanding disease biology to the implementation of novel processes in the clinical practice. The program will fund 14 excellent Doctoral Candidates (DCs) for a period of 48 months. DCs will perform collaborative PhD projects involving associated partners from different sectors, countries, and disciplines through secondments. DCs will improve their research capacity and transferable skills through high-quality supervision arrangements and a tailored training program.The program has been designed and will be hosted by the Josep Carreras Leukaemia Research Institute (IJC) which is the first European non-profit institute exclusively devoted to blood cancers. By answering the European needs for human resources, it is fully aligned with the 13 recommendations of the EU Cancer Board’s Draft Mission and the Europe’s Beating Cancer Plan (2021). The CarrerasPathfinder program has a strong triple-I dimension of internationality, inter-sectorality and interdisciplinarity in training, networking, co-supervision and research. Its specific objectives are:•To develop an excellent doctoral program in blood cancer research conceived as a pilot for a permanent international doctoral program•To equip DCs with a unique skill set boosting effectiveness and innovation capacity. •To promote DCs’ career development and increase their employability in different sectors.•To establish the IJC as a European reference for research and training in blood cancers.•To provide Europe with a new generation of researchers able to address unmet needs and societal challenges of blood cancers.•To contribute to structuring the European research area by collaborating and synergizing with other European key opinion leaders.

Original text from CORDIS.

Participants

• FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS · BadalonaCoordinatorSpain
• AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS · MadridSpain
• ANAXOMICS BIOTECH SL · BarcelonaSpain
• APPLIED NANOPARTICLES SL · BarcelonaSpain
• APPLIED RESEARCH USING OMIC SCIENCES SL · BarcelonaSpain
• ASOCIACION INNOLIFE SPAIN · BarcelonaSpain
• Asociación Española Contra el Cáncer · MadridSpain
• BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION · BARCELONASpain
• BIOCAT LA FUNDACIO BIOREGIO DE CATALUNYA · BarcelonaSpain
• BIOMEDICINSKE CENTRUM SLOVENSKEJ AKADEMIE VIED, VEREJNA VYSKUMNA INSTITUCIA · BratislavaSlovakia
• CHARITE - UNIVERSITAETSMEDIZIN BERLIN · BerlinGermany
• CONSORCIO PARA LA CONSTRUCCION EQUIPAMIENTO Y EXPLOTACION DEL LABORATORIO DE LUZ SINCROTRON · Cerdanyola Del Valles BarcelonaSpain
• DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG · HeidelbergGermany
• ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE · LausanneSwitzerland
• EUROPEAN HEMATOLOGY ASSOCIATION · DEN HAAGNetherlands
• FONDAZIONE PER L'ISTITUTO ONCOLOGICO DI RICERCA (IOR) · BELLINZONASwitzerland
• FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE · LISBOAPortugal
• FUNDACIO INSTITUCIO DELS CENTRES DE RECERCA DE CATALUNYA · BarcelonaSpain
• FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA) · BarcelonaSpain
• FUNDACION CIENTIFICA DE LA ASOCIACIÓN ESPANOLA CONTRA EL CANCER · MadridSpain
• FUNDACION PARA EL CONOCIMIENTO MADRIMASD · MadridSpain
• Fundació Internacional Josep Carreras · BarcelonaSpain
• Gavin LucasSpain
• HUMANITAS MIRASOLE SPA · Rozzano (Mi)Italy
• INSTITUTUL NATIONAL DE CERCETARE - DEZVOLTARE IN DOMENIUL PATOLOGIEI SI STIINTELOR BIOMEDICALE VICTOR BABES RA · BUCHARESTRomania
• International Society for Experimental Hematology · ChicagoUnited States
• MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV · MUNCHENGermany
• MESOESTETIC PHARMA GROUP S.L. · ViladecansSpain
• MLL MUNCHNER LEUKAMIELABOR GMBH · MunchenGermany
• NEW YORK UNIVERSITY · NEW YORKUnited States
• NOVOGENE UK COMPANY LIMITED · LondonUnited Kingdom
• ONECHAIN IMMUNOTHERAPEUTICS S.L. · BarcelonaSpain
• ONKOLOSKI INSTITUT LJUBLJANA · LjubljanaSlovenia
• QUIMATRYX SL · San SebastianSpain
• SCIENSEED SL · MADRIDSpain
• SEMMELWEIS EGYETEM · BudapestHungary
• Specialized Hospital for Active Treatment of Hematological Diseases · SofiaBulgaria
• TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK · New YorkUnited States
• UNIVERSITA DEGLI STUDI DI TORINO · TorinoItaly
• UNIVERSITAT AUTONOMA DE BARCELONA · Cerdanyola Del VallesSpain
• UNIVERSITAT DE BARCELONA · BarcelonaSpain
• UNIVERSITE LIBRE DE BRUXELLES · Bruxelles / BrusselBelgium
• UNIVERSITETET I OSLO · OsloNorway
• UNIVERSITY OF CYPRUS · NicosiaCyprus
• UNIVERSITY OF NEWCASTLE UPON TYNE · Newcastle Upon TyneUnited Kingdom
• UNIVERSITY OF SHARJAH · SharjahUnited Arab Emirates
• USTAV MOLEKULARNI GENETIKY AV CR V.V.I. · Praha 4Czechia

Links

• View on CORDIS
• DOI: 10.3030/101126688